Oncology PracticeNivolumab Wins First-Line Indication in Metastatic Urothelial CarcinomaMarch 8, 2024Genitourinary CancerPatient & Survivor CarePractice ManagementMixed Topics
Oncology PracticeTIL for Melanoma: What Are the Costs and Other Challenges to Getting It to Patients?March 8, 2024MelanomaImmunotherapyImmuno-oncologyPatient & Survivor CarePractice ManagementBusiness of MedicineMixed Topics
Oncology PracticeFirst Denosumab Biosimilar Approved in Two Different FormulationsMarch 6, 2024Lymphoma & Plasma Cell DisordersGenitourinary CancerBreast CancerMultiple Myeloma
Oncology PracticeFDA Approves Amivantamab First-line Indication for NSCLCMarch 4, 2024Lung CancerPatient & Survivor Care
Oncology PracticeFDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineBreast CancerCNS/Brain CancerDLBCLFollicular Lymphoma
Hematology NewsFDA Withdraws Melflufen Approval, but EMA Still Allows Its UseFebruary 29, 2024Multiple MyelomaPatient & Survivor CarePractice Management
Oncology PracticeFDA Rejects GI Cancer Drug Over Manufacturing IssuesJanuary 12, 2024Gastrointestinal CancerGastroenterologyPractice Management
Oncology PracticeFDA OKs capivasertib for certain advanced breast cancersNovember 17, 2023Breast Cancer
Hematology NewsFDA to step up oversight of cosmetics, assess ‘forever chemicals’August 31, 2023Mixed Topics
Oncology PracticeFDA OKs combo therapy of niraparib, abiraterone acetate for prostate cancerAugust 14, 2023Genitourinary CancerProstate Cancer
Oncology PracticeFDA clears AI-assisted colonoscopy deviceAugust 1, 2023Gastrointestinal CancerGastroenterologyPreventive Care
Oncology PracticeFDA approves talazoparib for metastatic prostate cancerJune 23, 2023Genitourinary CancerPatient & Survivor CarePractice Management
Oncology PracticeNew USPSTF draft suggests mammography start at 40, not 50May 9, 2023Preventive CareBreast Cancer
